Every investor in Hemogenyx Pharmaceuticals Plc (LON:HEMO) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 70% ownership.

LONDON, UK / ACCESSWIRE / July 10, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company ...

When asked when she knew she had what it took to be a New Jersey state wrestling champion, Cherry Hill East junior Maya Hemo laughed and said she didn’t. The 126-pounder got some validation when the ...

VANCOUVER, Aug. 29 - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced that the U.S. Food and Drug Administration (FDA) has given ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

EKF Diagnostics, the global in vitro diagnostics company, announces that it is supporting the reduction of anemia in developing regions of South America through the use of its point-of-care (POC) ...